Association of rare MSH6 variants with familial breast cancer
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
Physical activity levels after treatment for breast cancer: one-year follow-up
Final results of a phase II study of nab -paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
A pilot study of adjuvant nanoparticle albumin-bound ( nab ) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer
Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns
BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry
Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls
NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis
TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects
Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls
The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families
Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland
Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers